A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 3, 2006, Pages 384-393

  Gros, Edwige ^a   Deshayes, Sebastien ^a   Morris, May C ^a   Aldrian Herrada, Gudrun ^a   Depollier, Julien ^a   Heitz, Frederic ^a   Divita, Gilles ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

Amphipathic peptide; Cell penetrating peptide; Peptide delivery; Peptide nucleic acid; Peptide based nanoparticle; Therapeutic protein

Indexed keywords

CHARIOT; LYSINE; LYSYLGLUTAMYLTHREONYLTRYPTOPHYLTRYPTOPHYLGLUTAMYLTHREONYLTRYPTOPHYL TRYPTOPHYLTHREONYLGLUTAMYLTRYPTOPHYLSERYLGLUTAMINYLPROLYLLYSYLLYSYLLYSYLARGINYL LYSYLVALINE; NUCLEIC ACID; PEP 1 PEPTIDE; PEPTIDE DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE; CHEMICAL MODIFICATION; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; HUMAN; HYDROPHOBICITY; IN VIVO STUDY; MACROMOLECULE; NONHUMAN; NUCLEIC ACID TRANSPORT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYSTEAMINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; PEPTIDE NUCLEIC ACIDS; PEPTIDES; PROTEIN TRANSPORT; PROTEINS;

EID: 33646523661     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.02.006     Document Type: Article

References (91)

1. Langel U. Cell Penetrating peptides: Processes and application. Pharmacology and Toxicology Series (2002), CRC Press
2. Wadia J.S., and Dowdy S.F. Protein transduction technology. Curr. Opin. Biotechnol. 13 (2002) 52-56
3. Jolio A., and Prochiantz A. Transduction peptides: from technology to physiology. Nat. Cell Biol. 6 (2004) 189-196
4. Javer P., and Langel U. The use of cell-penetrating peptides as a toll for gene regulation. Drug Discov. Today 9 (2004) 395-402
5. Morris M.C., Chaloin L., Heitz F., and Divita G. Translocating peptides and proteins and their use for gene delivery. Curr. Opin. Biotechnol. 11 (2000) 461-466
6. Gariepy J., and Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol. 19 (2000) 21-26
7. Deshayes S., Morris M.C., Divita G., and Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell. Mol. Life Sci. 16 (2005) 839-849
8. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1998) 1189-1193
9. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 664-668
10. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
11. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
12. Derossi D., Joliot A.H., Chassaings G., and Prochiantz A. The third helix of the antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
13. Elliott G., and O'Hare P. Intercellular trafficking and protein delivery by a Herpesvirus structural protein. Cell 88 (1997) 223-233
14. Wender P.A., Mitchel D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13003-13008
15. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
16. Schmidt M.C., Rothen-Rutishauser B., Rist B., Beck-Sikinger A., Wunderli-Allenspach H., Rubas W., Sadee W., and Merkle H.P. Translocation of human calcitonin in respiratory nasal epithelium is associated with self assembly in lipid membrane. Biochemistry 37 (1998) 16582-16590
17. Krauss U., Muller M., Syahl M., and Beck-Sikinger A. In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. Bioorg. Med. Chem. Lett. 14 (2004) 51-54
18. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., and Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. U. S. A. 97 (2000) 8245-8250
19. Rouselle C., Clair P., Lefauconnier J.M., Kaczorek M., Scherrmann J.M., and Temsamani J. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol. Pharmacol. 57 (2000) 679-686
20. Pooga M., Kut C., Kihlmark M., Hallbrink M., Fernaeus S., Raid R., Land T., Hallberg E., Bartfai T., and Langel U. Cellular translocation of proteins by transportan. FASEB J. 8 (2001) 1451-1474
21. Gait M.J. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell. Mol. Life Sci. 60 (2003) 844-853
22. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., Becker-Hapak M., Ezhevsky S., and Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAp27kip1 induced cell migration. Nat. Med. 4 (1998) 1449-1452
23. Morris M.C., Depollier J., Mery J., Heitz F., and Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19 (2001) 1173-1176
24. Morris M.C., Depollier J., Heitz F., and Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells: application to the delivery of antibodies and therapeutic proteins. Handbook of Cell Biology (2006) 13-18 Chap. 2
25. Gallo G. Making proteins into drugs: assisted delivery of proteins and peptides into living neurons. Methods Cell Biol. 71 (2003) 325-338
26. Pratt R.L., and Kinch M.S. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene 21 (2002) 7690-7699
27. Aoshiba K., Yokohori N., and Nagai A. Alveolar wall apoptosis causes lung destruction and amphysematous changes. Am. J. Respir. Cell Mol. Biol. 28 (2003) 555-562
28. Wu Y., Wood M.D., Yi T.T., and Katagiri F. Direct delivery of bacterial avirulence proteins into resistant Arabidopsis protoplasts leads to hypersensitive cell death. Plant J. 33 (2002) 130-137
29. Maron M.B., Folkesson H.G., Stader S.M., and Walro J.M. PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization. Am. J. Physiol., Lung Cell. Mol. Physiol. 289 (2005) 349-354
30. Deshayes S., Heitz A., Morris M.C., Charnet P., Divita G., and Heitz F. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. Biochemistry 43 (2004) 1449-1457
31. Morris M.C., Vidal P., Chaloin L., Heitz F., and Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25 (1997) 2730-2736
32. Morris M.C., Chaloin L., Mery J., Heitz F., and Divita G. A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res. 27 (1999) 3510-3517
33. Mery J., Granier C., Juin M., and Brugidou J. Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides. Int. J. Pept. Protein Res. 42 (1993) 44-52
34. Morris M.C., Chaloin L., Choob M., Archdeacon J., Heitz F., and Divita G. The combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression. Gene Ther. 11 (2004) 757-764
35. Morris M.C., Robert-Hebmann V., Chaloin L., Mery J., Heitz F., Devaux C., Goody R.S., and Divita G. A new potent HIV-reverse transcriptase inhibitor: a synthetic peptide derived from interface subunit domains. J. Biol. Chem. 274 (1999) 24941-24946
36. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
37. Lundberg M., Wikstrom S., and Johansson M. Cell surface adherence and endocytosis of protein transduction domain. Mol. Ther. 8 (2003) 143-150
38. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., and Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 280 (2005) 15300-15306
39. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Kioke Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides; role of macropinocytosis and actin rearrangement. Mol. Ther. 10 (2004) 1011-1022
40. Wadia J., Stan R.V., and Dowdy S. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
41. Magzoub M., and Gräslund A. Cell-penetrating peptides: small from inception to application. Q. Rev. Biophys. 37 (2004) 147-195
42. Rothbard J.B., Jessop T.C., Lewis R.S., Murray B.A., and Wender P.A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126 (2004) 9506-9508
43. Terrone D., Leung Wai S., Sang Roudaia L., and Silvius J.R. Penetratin and related cell-penetrating cationic peptide can translocated across lipid bilayers in the presence of a transbilayer potential. Biochemistry 42 (2003) 13787-13799
44. Dom G., Shaw-Jackson C., Matis C., Bouffioux O., Picard J.J., Prochiantz A., Mingeot-Leclercq M.P., Brasseur R., and Rezsohazy R. Cellular uptake of Antennapedia Penetratin peptides is a two step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acid Res. 31 (2003) 556-561
45. Thoren P.E., Persson D., Isakson P., Goksör M., Önfelt A., and Nordèn B. Uptake of analogs of penetratin, Tat (48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307 (2003) 100-107
46. Magzoub M., Eriksson L.E.G., and Grâslund A. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipids vesicles. Biophys. Chem. 103 (2003) 271-288
47. Deshayes S., Plenat T., Aldrian-Herrada G., Divita G., Le Grimellec C., and Heitz F. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. Biochemistry 43 (2004) 7698-7706
48. Deshayes S., Gerbal-Chaloin S., Morris M.C., Aldrian-Herrada G., Charnet P., Divita G., and Heitz F. On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids. Biochim. Biophys. Acta 1667 (2004) 141-147
49. Chariot™ profile:/http://www.active.motif.com.
50. Gallo G., Yee H.F., and Letourneau P.C. Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility. J. Cell Biol. 158 (2002) 1219-1228
51. Garnon J., Lachance C., Di Marco S., Hel Z., Marion D., Ruiz M.C., Newkirk M.M., Khandjian F.W., and Radzioch D. Fragile X-related protein FXR1P regulates proinflammatory cytokine TNF expression at the posttranscriptional level. J. Biol. Chem. 280 (2005) 5750-5763
52. Badag-Gorce F., Riley N., Nguyen V., Montgomery R.O., French B.A., Li F.W., Van Leeuwen W., Lungo L.W., McPhaul L.W., and French S.W. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB1). Exp. Mol. Pathol. 74 (2003) 160-167
53. Gehler S., Shaw A.E., Sarmiere P.D., Bamburg J.R., and Letourneau P.C. Brain-derived neutrophic factor regulation of retinal growth cone filopodial dynamics is mediated through actin depolymerizing factor/cofilin. J. Neurosci. 24 (2004) 10741-10749
54. Chan S.A., Polo-Parada L., Landmesser L.T., and Smith C. Adrenal chromaffin cells exhibit impaired granule trafficking in NCAM knockout mice. J. Neurophysiol. 94 (2005) 1037-1047
55. Pandey A.V., Mellon S.H., and Miller W.L. Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J. Biol. Chem. 278 (2003) 2837-2844
56. Jurney W.M., Gallo G., Letourneau P.C., and McLoon S.C. Rac1-mediated endocytosis during ephrin-A2- and semaphorin 3A-induced growth cone collapse. J. Neurosci. 22 (2002) 6019-6028
57. Morgan D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13 (1997) 261-291
58. Snyder E.L., Meade B.R., and Dowdy S.F. Anti-cancer protein transduction strategies: restitution of p27 tumor suppressor function. J. Control. Release 91 (2003) 45-51
59. Zavaglia D., Favrot M.C., Eymin B., Tenaud C., and Coll J.L. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein. Gene Ther. 10 (2003) 314-325
60. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., and Serhan C.N. Stereochemical assignment, anti-inflammatory properties and receptors for the omega-3 lipid mediator resolving E1. J. Exp. Med. 201 (2005) 713-722
61. Kowolik C.M., Yam P., Yu Y., and Yee J.K. HIV vector production mediated by Rev protein transduction. Mol. Ther. 2 (2003) 324-331
62. Mattheakis L.C., Dias J.M., Choi Y.J., Gong J., Bruchez M.P., Liu J., and Wang E. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 327 (2004) 200-210
63. Pooga M., Soomets U., Hallbrink M., Valkna A., Saar K., Rezaei K., Kahl U., Hao JX., Xu X.J., Wiesenfeld-Hallin Z., Hokfelt T., Bartfai T., and Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16 (1998) 857-861
64. Koppelhus U., and Nielsen P.E. Cellular delivery of peptide nucleic acid. Adv. Drug Deliv. Rev. 55 (2003) 267-280
65. Efimov V., Choob M., Buryakova A., Phelan D., and Chakhmakhcheva O. PNA-related oligonucleotide mimics and their evaluation for nucleic acid hybridization studies and analysis. Nucleosides Nucleotides Nucleic Acids 20 (2001) 419-428
66. Nan L., Wu Y., Bardag-Gorce F., Li J., French BA., Wilson L.T., Khanh Nguyen S., and French S.W. RNA interference of VCP/p97 increases Mallory body formation. Exp. Mol. Pathol. 78 (2005) 1-9
67. Eum W.S., Kim D.W., Hwang I.K., Yoo K.Y., Kang T.C., Jang S.H., Choi H.S., Choi S.H., Kim Y.H., Kim S.Y., Kwon H.Y., Kang J.H., Kwon O.S., Cho S.W., Lee K.S., Park J., Won M.H., and Choi S.Y. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult. Free Radic. Biol. Med. 37 (2004) 1656-1669
68. E. Gros, M.C. Morris, G. Aldrian-Herrada, F. Heitz, G. Divita, personal communication.
69. Gondeau C., Chaloin-Gerbal S., Bello P., Aldrian-Herrada G., Morris M.C., and Divita G. Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. J. Biol. Chem. 280 (2005) 13793-13800
70. Payne C., Rawe V., Ramalho-Santos J., Simerly C., and Schatten G. Preferentially localized dynein and perinuclear dynactin associate with nuclear pore complex proteins to mediate genomic union during mammalian fertilization. J. Cell Sci. 116 (2003) 4727-4738
71. Rawe V.Y., Payne C., Navara C., and Schatten G. WAVE1 intranuclear trafficking is essential for genomic and cytoskeletal dynamics during fertilization: cell-cycle-dependent shuttling between M-phase and interphase nuclei. Dev. Biol. 276 (2004) 253-267
72. Michiue H., Tomizawa K., Wei F.-Y., Matsushita M., Lu Y.-F., Ichikawa T., Tamiya T., Dates I., and Matsui H. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J. Biol. Chem. 280 (2005) 8285-8289
73. Li X., Hummer A., Han J., Xie M., Melnik-Martinez K., Moreno R.L., Buck M., Mark M.D., and Herlitze S. G protein β2 subunit derived peptides for inhibition and induction of G protein pathways. J. Biol. Chem. 280 (2005) 23945-23959
74. Yokoyama N., Ischenko I., Hayman M.J., and Miller W.T. The C-terminus of the RON tyrosine kinase plays an auto inhibitory role. J. Biol. Chem. 280 (2005) 8893-8900
75. Zhang Q., Hottke A., and Goodman R.H. Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2802-2807
76. Zhou J., and Hsieh J.T. The inhibitory role of DOC-2/DAB2 in growth factor receptor mediated signal cascade. J. Biol. Chem. 276 (2001) 27793-27798
77. Couplier M., Anders J., and Ibanez C.F. Coordinated activation of autophosphorylation sites in the RET receptor Tyrosine kinase. J. Biol. Chem. 277 (2002) 1991-1999
78. Goska M.M., Stafford S.J., Cen O., Sur S., and Alam R. Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J. Exp. Med. 199 (2004) 369-379
79. Buster D., McNally K., and McNally F.J. Katanin inhibition prevents the redistribution of α-tubulin at mitosis. J. Cell Sci. 115 (2002) 1083-1092
80. Aki T., Kimura M., Nakamura K., Nao T., Okusa T., Matsuzaki M., Yoshida K., Kobayashi S., Mizukami Y., and Iwamatsu A. ERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenation. J. Biol. Chem. 279 (2004) 50120-50131
81. Cen O., Gorska M.M., Stafford S.J., Sur S., and Alam R. Identification of UNC119 as a novel activator of SRC-type tyrosine kinases. J. Biol. Chem. 278 (2003) 8837-8845
82. Sorenson C.M. Interaction of bcl-2 with Paxillin through its BH4 domain is important during ureteric bud branching. J. Biol. Chem. 279 (2004) 11368-11374
83. Sebbagh M., Hamelin J., Bertoglio J., Solary E., and Breard J. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J. Exp. Med. 201 (2005) 465-471
84. Jiang J., Borisenko G.G., Osipov A., Martin I., Chen R., Shvedova A.A., Sorokin A., Tyurina Y.Y., Potapovich A., Tyurin V.A., Graham S.H., and Kagan V.E. Arachidonic acid-induced carbon-centered radicals and phospholipid peroxidation in cyclo-oxygenase-2-transfected PC12 cells. J. Neurochem. 90 (2004) 1036-1049
85. Tisdale E.J. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota/lambda and plays a role in microtubule dynamics in the early secretory pathway. J. Biol. Chem. 277 (2002) 3334-3341
86. Tassa A., Roux M.P., Attaix D., and Bechet D.M. Class III phosphoinositide 3-kinase-Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. Biochem. J. 376 (2003) 577-586
87. Heerssen H.M., Pazyra M.F., and Segal R.A. Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat. Neurosci. 6 (2004) 596-604
88. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., and Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303 (2004) 1010-1014
89. van der Wijk T., Tomassen S.F., Houtsmuller A.B., de Jonge H.R., and Tilly B.C. Increased vesicle recycling in response to osmotic cell swelling. Cause and consequence of hypotonicity-provoked ATP release. J. Biol. Chem. 278 (2003) 40020-40025
90. Taneja N., Davis M., Choy J.S., Beckett M.A., Singh R., Kron S.J., and Weichselbaum R.R. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J. Biol. Chem. 279 (2004) 2273-2280
91. Eskiw C.H., Dellaire G., and Bazett-Jones D.P. Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J. Biol. Chem. 279 (2004) 9577-9585